<DOC>
	<DOC>NCT01945840</DOC>
	<brief_summary>The purpose of this study is to assess whether the changes in gut hormones seen following Roux en Y Gastric Bypass surgery are responsible for some of the beneficial effects seen post-operatively.</brief_summary>
	<brief_title>Gut Hormones and Roux en Y Gastric Bypass</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<criteria>Body mass index ≤50 kg/m2. Eligible for bariatric surgery under the NHS. Diagnosed with impaired glucose regulation or type 2 diabetes, according to WHO 2011 criteria. For the dose finding study, nondiabetics can also be recruited. Those with diabetes should be stable and well controlled with either diet or one oral hypoglycaemic agent. HbA1c ≤8.0% or 64 mmol/mol. History of any medical, psychological or other condition, or use of any medications, including overthecounter products, which, in the opinion of the investigators, would either interfere with the study or potentially cause harm to the volunteer. Without access at home to a telephone or other factor likely to interfere with ability to participate reliably in the study. Pregnancy or breastfeeding. Smokers. Unable to maintain adequate contraception for the duration of the study and for one month afterwards. History of hypersensitivity to any of the components of the subcutaneous infusions. Donated blood during the preceding 3 months or intention to do so before the end of the study. Insulin treatment. Uncontrolled hypertension. Any other comorbidity that would compromise the validity of the study or the safety of the participant such as heart failure, clinically apparent cardiovascular disease. Unable to give informed consent. Previous bariatric surgery. Unable to undergo fMRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>